CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Minerva Neurosciences, Inc.

NERV
$172MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for NERV. That does not mean none is planned.

Get an email about NERV's next catalysts

Track Minerva Neurosciences (NERV) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 2 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaBURLINGTON
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Minerva Neurosciences, Inc.'s drug pipeline?β†’

CatalystAlert tracks 2 drug candidates in Minerva Neurosciences, Inc.'s (NERV) pipeline across Phase 3, Phase 2. Its lead program is Roluperidone (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Minerva Neurosciences, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Minerva Neurosciences, Inc. (NERV) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track NERV biotech catalysts?β†’

Add NERV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Minerva Neurosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply